Cullinan Therapeutics (CGEM) Q4 2022 Earnings

9MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.97
1.16
3.29
5.42

Details

Expected EPS
-0.66
Actual EPS
-0.59
Surprise EPS
0.07
Surprise Percent
+10.61%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -0.59 per share for Q4 2022.

0 Comments

Share your thoughts